COVIFENZ Trademark

Trademark Overview

On Friday, May 21, 2021, a trademark application was filed for COVIFENZ with the United States Patent and Trademark Office. The USPTO has given the COVIFENZ trademark a serial number of 79316789. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by Medicago inc.. The COVIFENZ trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccines for preventing and treating coronaviruses diseases and disorders
covifenz

General Information

Serial Number79316789
Word MarkCOVIFENZ
Filing DateFriday, May 21, 2021
Status700 - REGISTERED
Status DateTuesday, February 21, 2023
Registration Number6982394
Registration DateTuesday, February 21, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements

Description of MarkThe mark consists of the stylized wording COVIFENZ featuring a leaf above the letter I.
Goods and ServicesHuman vaccines for preventing and treating coronaviruses diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedicago inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCA
Party NameMedicago inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCA
Party NameMedicago inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events

Event DateEvent Description
Sunday, June 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 22, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 22, 2023FINAL DISPOSITION PROCESSED
Sunday, May 21, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 21, 2023REGISTERED-PRINCIPAL REGISTER
Monday, January 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Monday, December 5, 2022NOTIFICATION PROCESSED BY IB
Wednesday, November 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 16, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 24, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 23, 2022REFUSAL PROCESSED BY IB
Monday, January 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 3, 2022REFUSAL PROCESSED BY MPU
Thursday, December 23, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 22, 2021NON-FINAL ACTION WRITTEN
Tuesday, December 14, 2021ASSIGNED TO EXAMINER
Saturday, August 14, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, August 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 29, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

covifenz diseases disorders coronaviruses treating vaccines preventing human